Altium Capital Management LP - Q1 2022 holdings

Add to watchlist

$299 Million is the total value of Altium Capital Management LP's 118 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 60.9% .

All

			Value		Shares		↓ Weighting
PTGX	New	PROTAGONIST THERAPEUTICS INCcall	$11,840,000	–	5,000	+100.0%	3.96%	–
ESPR	Sell	ESPERION THERAPEUTICS INC NE	$11,584,000	-7.9%	2,496,524	-0.8%	3.88%	+11.8%
BLU		BELLUS HEALTH INC NEW	$9,976,000	-14.5%	1,450,006	0.0%	3.34%	+3.7%
PTGX	Buy	PROTAGONIST THERAPEUTICS INC	$9,140,000	-22.8%	386,000	+11.6%	3.06%	-6.3%
KDNY		CHINOOK THERAPEUTICS INC	$8,916,000	+0.3%	545,000	0.0%	2.98%	+21.7%
	New	PEPPERLIME HEALTH ACQUSTN COunit 99/99/9999	$7,232,000	–	735,000	+100.0%	2.42%	–
KROS	Buy	KEROS THERAPEUTICS INC	$6,852,000	+1.0%	126,000	+8.6%	2.29%	+22.6%
DXCM	New	DEXCOM INC	$6,395,000	–	12,500	+100.0%	2.14%	–
INSM	Buy	INSMED INC	$6,298,000	+13.7%	268,000	+31.8%	2.11%	+38.0%
QDEL	Buy	QUIDEL CORP	$6,298,000	+26.1%	56,000	+51.4%	2.11%	+53.1%
ADMA		ADMA BIOLOGICS INC	$6,039,000	+29.8%	3,300,000	0.0%	2.02%	+57.5%
GMED	Buy	GLOBUS MED INCcl a	$5,829,000	+36.8%	79,000	+33.9%	1.95%	+66.0%
TNDM	New	TANDEM DIABETES CARE INC	$5,815,000	–	50,000	+100.0%	1.95%	–
NVRO	Buy	NEVRO CORP	$5,569,000	+63.6%	77,000	+83.3%	1.86%	+98.5%
RLMD		RELMADA THERAPEUTICS INC	$5,560,000	+19.8%	206,000	0.0%	1.86%	+45.4%
CBAY		CYMABAY THERAPEUTICS INC	$5,443,000	-8.0%	1,750,000	0.0%	1.82%	+11.7%
GKOS	Buy	GLAUKOS CORP	$5,435,000	+51.0%	94,000	+16.0%	1.82%	+83.2%
BCYC	Sell	BICYCLE THERAPEUTICS PLCsponsored ads	$5,266,000	-49.7%	120,000	-30.2%	1.76%	-39.0%
NVST	New	ENVISTA HOLDINGS CORPORATION	$5,115,000	–	105,000	+100.0%	1.71%	–
MBTC		NOCTURNE ACQUISITION CORPordinary shares	$5,040,000	+0.8%	500,000	0.0%	1.69%	+22.3%
SWAV	New	SHOCKWAVE MED INC	$4,769,000	–	23,000	+100.0%	1.60%	–
KPTI	New	KARYOPHARM THERAPEUTICS INC	$4,754,000	–	645,000	+100.0%	1.59%	–
QGEN		QIAGEN NV	$4,557,000	-11.8%	93,000	0.0%	1.52%	+7.0%
RNA	Buy	AVIDITY BIOSCIENCES INC	$4,488,000	-16.1%	243,000	+8.0%	1.50%	+1.8%
CRNX	Sell	CRINETICS PHARMACEUTICALS IN	$4,478,000	-52.4%	204,000	-38.4%	1.50%	-42.2%
IMGN	New	IMMUNOGEN INC	$4,379,000	–	920,000	+100.0%	1.46%	–
XTNT		XTANT MED HLDGS INC	$4,247,000	+21.4%	6,246,291	0.0%	1.42%	+47.4%
VSTM	Buy	VERASTEM INC	$4,161,000	-9.9%	2,951,000	+31.0%	1.39%	+9.3%
INSP	Sell	INSPIRE MED SYS INC	$4,107,000	-22.4%	16,000	-30.4%	1.37%	-5.8%
LIVN	New	LIVANOVA PLC	$4,092,000	–	50,000	+100.0%	1.37%	–
ISEE	Sell	IVERIC BIO INC	$3,972,000	-27.8%	236,000	-28.3%	1.33%	-12.4%
EUCR		EUCRATES BIOMEDICAL ACQU COR	$3,936,000	+0.8%	400,000	0.0%	1.32%	+22.4%
ILMN	Sell	ILLUMINA INC	$3,843,000	-42.3%	11,000	-37.1%	1.29%	-30.0%
GOEDWS		1847 GOEDEKER INC*w exp 06/02/202	$3,778,000	-48.8%	6,103,824	0.0%	1.26%	-37.9%
EIGR	Buy	EIGER BIOPHARMACEUTICALS INC	$3,652,000	+169.5%	440,000	+68.6%	1.22%	+226.7%
OCUL		OCULAR THERAPEUTIX INC	$3,440,000	-29.0%	695,000	0.0%	1.15%	-13.8%
IMUX	Sell	IMMUNIC INC	$3,390,000	+11.7%	300,000	-5.4%	1.14%	+35.6%
ACET	Sell	ADICET BIO INC	$3,095,000	-32.7%	155,000	-41.1%	1.04%	-18.3%
MYGN	Sell	MYRIAD GENETICS INC	$2,891,000	-44.9%	114,710	-39.6%	0.97%	-33.1%
KRMD		REPRO MED SYS INC	$2,847,000	-4.7%	995,500	0.0%	0.95%	+15.7%
EYPT	Sell	EYEPOINT PHARMACEUTICALS INC	$2,728,000	-0.9%	224,541	-0.2%	0.91%	+20.3%
KRTX	New	KARUNA THERAPEUTICS INC	$2,663,000	–	21,000	+100.0%	0.89%	–
TMPM		TURMERIC ACQUISITION CORPcl a	$2,502,000	+0.3%	254,000	0.0%	0.84%	+21.7%
MORF		MORPHIC HLDG INC	$2,409,000	-15.3%	60,000	0.0%	0.81%	+2.8%
OM	New	OUTSET MED INC	$2,361,000	–	52,007	+100.0%	0.79%	–
	Buy	HILLMAN SOLUTIONS CORP	$2,328,000	+52.5%	196,000	+38.0%	0.78%	+85.0%
CLDX	Sell	CELLDEX THERAPEUTICS INC NEW	$2,248,000	-53.8%	66,000	-47.6%	0.75%	-44.0%
SRSA		SARISSA CAPITAL ACQUISITN COcl a	$2,228,000	+1.1%	225,000	0.0%	0.75%	+22.9%
LNTH	Sell	LANTHEUS HLDGS INC	$2,212,000	-71.9%	40,000	-85.3%	0.74%	-65.9%
SLN	New	SILENCE THERAPEUTICS PLCads	$2,071,000	–	109,000	+100.0%	0.69%	–
CARA	New	CARA THERAPEUTICS INC	$2,005,000	–	165,000	+100.0%	0.67%	–
		TG VENTURE ACQUISITION CORPunit 08/15/2028	$2,004,000	-2.2%	200,000	0.0%	0.67%	+18.8%
		GIGINTERNATIONAL1 INC	$2,000,000	+0.7%	200,000	0.0%	0.67%	+22.1%
		LAKESHORE ACQUISITION I CORPordinary shares	$1,982,000	+0.5%	200,000	0.0%	0.66%	+21.9%
		CHAVANT CAPITAL ACQUISITN COordinary shares	$1,982,000	+0.7%	200,000	0.0%	0.66%	+22.1%
JYAC		JIYA ACQUISITION CORP	$1,966,000	+0.6%	200,000	0.0%	0.66%	+22.1%
	New	2SEVENTY BIO INC	$1,962,000	–	115,000	+100.0%	0.66%	–
ALT	New	ALTIMMUNE INC	$1,961,000	–	322,000	+100.0%	0.66%	–
AGIO	New	AGIOS PHARMACEUTICALS INC	$1,927,000	–	66,196	+100.0%	0.64%	–
GBT		GLOBAL BLOOD THERAPEUTICS IN	$1,871,000	+18.3%	54,000	0.0%	0.63%	+43.6%
	Buy	PARDES BIOSCIENCES INC	$1,827,000	-44.2%	253,000	+26.5%	0.61%	-32.3%
CTMX		CYTOMX THERAPEUTICS INC	$1,772,000	-38.3%	663,800	0.0%	0.59%	-25.1%
		RENOVACOR INC	$1,649,000	-44.9%	388,845	0.0%	0.55%	-33.2%
	New	PROCEPT BIOROBOTICS CORP	$1,647,000	–	47,077	+100.0%	0.55%	–
		DIGITAL HEALTH ACQUISITION Cunit 11/02/2026	$1,515,000	-1.4%	150,000	0.0%	0.51%	+19.6%
	New	AULT DISRUPTIVE TECHS CORP	$1,496,000	–	150,000	+100.0%	0.50%	–
	New	SOMALOGIC INC	$1,444,000	–	180,000	+100.0%	0.48%	–
CTIC	Sell	CTI BIOPHARMA CORP	$1,400,000	-74.2%	299,800	-86.3%	0.47%	-68.6%
ITCI	New	INTRA-CELLULAR THERAPIES INC	$1,377,000	–	22,500	+100.0%	0.46%	–
CRIS	Sell	CURIS INC	$1,287,000	-67.4%	540,800	-34.8%	0.43%	-60.4%
TWND		TAILWIND ACQUISITION CORP	$1,271,000	+0.6%	128,414	0.0%	0.42%	+21.8%
PROF	Sell	PROFOUND MED CORP	$1,125,000	-66.6%	124,945	-58.4%	0.38%	-59.5%
CUTR	New	CUTERA INC	$1,035,000	–	15,000	+100.0%	0.35%	–
FATBW		FAT BRANDS INC*w exp 07/16/202	$1,022,000	-33.3%	227,000	0.0%	0.34%	-19.1%
	New	MURPHY CANYON ACQUISITION COunit 01/25/2027	$1,010,000	–	100,000	+100.0%	0.34%	–
	New	RELATIVITY ACQUISITION CORPunit 02/10/2027	$1,007,000	–	100,000	+100.0%	0.34%	–
	New	WESTERN ACQSTN VENTURES CORPunit 09/01/2026	$1,000,000	–	100,000	+100.0%	0.34%	–
		INDUSTRIAL HUMAN CAPITAL INC	$1,002,000	+1.0%	100,000	0.0%	0.34%	+22.3%
BLSA		BCLS ACQUISITION CORP	$987,000	+0.7%	100,000	0.0%	0.33%	+22.2%
OMEG		OMEGA ALPHA SPACcl a	$982,000	+0.5%	100,000	0.0%	0.33%	+22.3%
	New	OPY ACQUISITION CORP I	$980,000	–	100,000	+100.0%	0.33%	–
ARYD		ARYA SCIENCES ACQU CORP IVcl a	$980,000	-1.2%	100,000	0.0%	0.33%	+19.7%
GRIL	Sell	MUSCLE MAKER INC	$948,000	-34.0%	1,796,961	-10.0%	0.32%	-19.9%
		ACHIEVE LIFE SCIENCES INC	$924,000	-2.6%	122,000	0.0%	0.31%	+17.9%
		COLISEUM ACQUISITION CORP	$825,000	-0.1%	85,000	0.0%	0.28%	+21.1%
VQSLF	Sell	VIQ SOLUTIONS INC	$798,000	-51.4%	489,417	-30.5%	0.27%	-41.1%
VRCA		VERRICA PHARMACEUTICALS INC	$794,000	-11.5%	97,887	0.0%	0.27%	+7.7%
		DOUBLEDOWN INTERACTIVE CO LTads	$722,000	-23.5%	60,876	0.0%	0.24%	-6.9%
	New	GSR II METEORA ACQUISITN CORunit 02/24/2027	$506,000	–	50,000	+100.0%	0.17%	–
CLBR		COLOMBIER ACQUISITION CORPcl a	$484,000	+0.4%	50,000	0.0%	0.16%	+21.8%
	New	TC BIOPHARM HOLDINGS PLC*w exp 02/08/202	$461,000	–	941,176	+100.0%	0.15%	–
ZEVWS	New	LIGHTNING EMOTORS INC*w exp 05/18/202	$268,000	–	652,173	+100.0%	0.09%	–
		RENOVACOR INC*w exp 99/99/999	$249,000	-40.3%	731,561	0.0%	0.08%	-27.8%
		HARBOR CUSTOM DEVELOPMENT IN*w exp 10/04/202	$240,000	-52.1%	650,000	0.0%	0.08%	-42.0%
		SURGEPAYS INC*w exp 10/22/202	$223,000	+38.5%	250,000	0.0%	0.08%	+70.5%
HCDIW		HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202	$171,000	-26.9%	600,000	0.0%	0.06%	-12.3%
IMTXW		IMMATICS N.V*w exp 07/01/202	$171,000	-60.0%	97,467	0.0%	0.06%	-51.7%
	New	CEA INDUSTRIES INC*w exp 02/11/202	$171,000	–	250,000	+100.0%	0.06%	–
		PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202	$152,000	-7.9%	367,500	0.0%	0.05%	+13.3%
	New	DIRECT DIGITAL HOLDINGS INC*w exp 02/15/202	$131,000	–	180,000	+100.0%	0.04%	–
		CINGULATE INC*w exp 12/03/202	$108,000	-43.8%	270,000	0.0%	0.04%	-32.1%
MBTCR		NOCTURNE ACQUISITION CORPright 12/26/2025	$105,000	-47.5%	500,000	0.0%	0.04%	-36.4%
HSAQ		HEALTH SCIENCES ACQ CORP 2	$99,000	-2.0%	10,000	0.0%	0.03%	+17.9%
		NEXGEL INC*w exp 12/01/202	$88,000	-51.6%	225,000	0.0%	0.03%	-42.0%
CALA	New	CALITHERA BIOSCIENCES INC	$82,000	–	202,276	+100.0%	0.03%	–
NLSPW		NLS PHARMACEUTICS LTD*w exp 09/25/202	$76,000	-47.9%	200,000	0.0%	0.02%	-37.5%
		LAKESHORE ACQUISITION I CORP*w exp 07/15/202	$53,000	-54.3%	150,000	0.0%	0.02%	-43.8%
		CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999	$30,000	-59.5%	150,000	0.0%	0.01%	-50.0%
SRSAW		SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202	$27,000	-62.0%	75,000	0.0%	0.01%	-55.0%
EUCRW		EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202	$25,000	-67.5%	133,333	0.0%	0.01%	-61.9%
TMPMW		TURMERIC ACQUISITION CORP*w exp 10/08/202	$24,000	-52.9%	84,666	0.0%	0.01%	-42.9%
	New	OPY ACQUISITION CORP I*w exp 09/22/202	$20,000	–	50,000	+100.0%	0.01%	–
		SURROZEN INC*w exp 08/01/203	$21,000	-77.9%	82,233	0.0%	0.01%	-73.1%
	New	AULT DISRUPTIVE TECHS CORP*w exp 99/99/999	$19,000	–	112,500	+100.0%	0.01%	–
		GIGINTERNATIONAL1 INC*w exp 04/19/202	$18,000	-37.9%	50,000	0.0%	0.01%	-25.0%
		INDUSTRIAL HUMAN CAPITAL INC*w exp 11/27/202	$18,000	-52.6%	100,000	0.0%	0.01%	-40.0%
		COLISEUM ACQUISITION CORP*w exp 08/22/202	$10,000	-56.5%	28,333	0.0%	0.00%	-50.0%
CLBRWS		COLOMBIER ACQUISITION CORP*w exp 99/99/999	$5,000	-44.4%	16,666	0.0%	0.00%	0.0%
UPHWS	Exit	UPHEALTH INC*w exp 06/08/202	$0	–	-10,000	-100.0%	-0.00%	–
	Exit	RESERVOIR MEDIA INC*w exp 08/26/202	$0	–	-50,000	-100.0%	-0.02%	–
	Exit	NEXGEL INC	$0	–	-28,570	-100.0%	-0.02%	–
	Exit	MY SIZE INC	$0	–	-416,589	-100.0%	-0.06%	–
	Exit	AGILETHOUGHT INC	$0	–	-47,670	-100.0%	-0.06%	–
	Exit	CINGULATE INC	$0	–	-83,931	-100.0%	-0.06%	–
HSDT	Exit	HELIUS MED TECHNOLOGIES INC	$0	–	-48,862	-100.0%	-0.07%	–
	Exit	MDXHEALTH SAsponsored ads	$0	–	-36,159	-100.0%	-0.10%	–
	Exit	IMMIX BIOPHARMA INC	$0	–	-122,388	-100.0%	-0.12%	–
PALI	Exit	PALISADE BIO INC	$0	–	-333,954	-100.0%	-0.12%	–
ICAD	Exit	ICAD INC	$0	–	-63,929	-100.0%	-0.13%	–
	Exit	STRYVE FOODS INC	$0	–	-162,121	-100.0%	-0.18%	–
CNTB	Exit	CONNECT BIOPHARMA HLDGS LTDads	$0	–	-175,000	-100.0%	-0.25%	–
BBIO	Exit	BRIDGEBIO PHARMA INCcall	$0	–	-54,300	-100.0%	-0.25%	–
FMAC	Exit	FIRSTMARK HORIZON ACQUISITIO	$0	–	-100,000	-100.0%	-0.27%	–
	Exit	OPY ACQUISITION CORP Iunit 09/22/2026	$0	–	-100,000	-100.0%	-0.28%	–
MOTV	Exit	MOTIVE CAPITAL CORP	$0	–	-102,099	-100.0%	-0.28%	–
RZLT	Exit	REZOLUTE INC	$0	–	-230,000	-100.0%	-0.30%	–
CCAC	Exit	CITIC CAPITAL ACQUISITION CO	$0	–	-111,200	-100.0%	-0.31%	–
	Exit	CONTEXT THERAPEUTICS INC	$0	–	-493,531	-100.0%	-0.36%	–
AGLE	Exit	AEGLEA BIOTHERAPEUTICS INC	$0	–	-293,764	-100.0%	-0.38%	–
KALV	Exit	KALVISTA PHARMACEUTICALS INC	$0	–	-111,834	-100.0%	-0.41%	–
FLUX	Exit	FLUX PWR HLDGS INC	$0	–	-346,268	-100.0%	-0.41%	–
	Exit	AULT DISRUPTIVE TECHS CORPunit 99/99/9999	$0	–	-150,000	-100.0%	-0.42%	–
CELC	Exit	CELCUITY INC	$0	–	-145,000	-100.0%	-0.53%	–
ETNB	Exit	89BIO INC	$0	–	-148,000	-100.0%	-0.53%	–
DYN	Exit	DYNE THERAPEUTICS INC	$0	–	-166,636	-100.0%	-0.55%	–
CRDF	Exit	CARDIFF ONCOLOGY INC	$0	–	-337,000	-100.0%	-0.56%	–
MDGL	Exit	MADRIGAL PHARMACEUTICALS INC	$0	–	-24,000	-100.0%	-0.56%	–
LEGN	Exit	LEGEND BIOTECH CORPsponsored ads	$0	–	-50,000	-100.0%	-0.64%	–
STAA	Exit	STAAR SURGICAL CO	$0	–	-26,000	-100.0%	-0.66%	–
HLXA	Exit	HELIX ACQUISITION CORP	$0	–	-250,000	-100.0%	-0.68%	–
HCDIP	Exit	HARBOR CUSTOM DEVELOPMENT IN8% conv pfd sr a	$0	–	-185,000	-100.0%	-0.80%	–
ATEC	Exit	ALPHATEC HLDGS INC	$0	–	-255,000	-100.0%	-0.80%	–
INFU	Exit	INFUSYSTEM HLDGS INC	$0	–	-175,000	-100.0%	-0.82%	–
CERS	Exit	CERUS CORP	$0	–	-465,000	-100.0%	-0.87%	–
SIEN	Exit	SIENTRA INC	$0	–	-866,000	-100.0%	-0.88%	–
NTRA	Exit	NATERA INC	$0	–	-35,000	-100.0%	-0.90%	–
EXAS	Exit	EXACT SCIENCES CORP	$0	–	-44,000	-100.0%	-0.94%	–
AVDL	Exit	AVADEL PHARMACEUTICALS PLCsponsored adr	$0	–	-440,589	-100.0%	-0.98%	–
SYRS	Exit	SYROS PHARMACEUTICALS INC	$0	–	-1,160,000	-100.0%	-1.04%	–
KLR	Exit	KALEYRA INC	$0	–	-433,892	-100.0%	-1.20%	–
TVTX	Exit	TRAVERE THERAPEUTICS INC	$0	–	-141,000	-100.0%	-1.21%	–
EPIX	Exit	ESSA PHARMA INC	$0	–	-345,000	-100.0%	-1.35%	–
IOVA	Exit	IOVANCE BIOTHERAPEUTICS INCcall	$0	–	-300,000	-100.0%	-1.58%	–
NSTG	Exit	NANOSTRING TECHNOLOGIES INC	$0	–	-146,500	-100.0%	-1.71%	–
IMTX	Exit	IMMATICS N.V	$0	–	-469,980	-100.0%	-1.74%	–
	Exit	PEPPERLIME HEALTH ACQUSTN CO	$0	–	-735,000	-100.0%	-1.99%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2022-05-16

Signatures

The EDGAR filing(s) were signed by:

Mark Gottlieb — Chief Operating Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
FAT BRANDS INC	12	Q3 2023	0.6%
CHINOOK THERAPEUTICS INC	11	Q2 2023	8.9%
BELLUS HEALTH INC NEW	10	Q1 2023	4.7%
XTANT MED HLDGS INC	10	Q3 2023	5.1%
IVERIC BIO INC	10	Q1 2023	2.3%
MYRIAD GENETICS INC	10	Q1 2023	2.3%
HARBOR CUSTOM DEVELOPMENT IN	10	Q3 2023	0.1%
CRINETICS PHARMACEUTICALS IN	9	Q3 2023	4.1%
CTI BIOPHARMA CORP	9	Q1 2023	2.6%
POLISHED COM INC	9	Q2 2023	3.4%

View Altium Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)

Altium Capital Management LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Marpai, Inc.	April 26, 2023	1,805,327	6.2%
Astria Therapeutics, Inc.	February 14, 2023	1,355,372	5.0%
HyreCar Inc.	February 14, 2023	1,688,120	5.6%
Muscle Maker, Inc.	February 14, 2023	2,888,085	5.0%
NeuroBo Pharmaceuticals, Inc.^{Sold out}	February 14, 2023	0	0.0%
PALISADE BIO, INC.^{Sold out}	February 14, 2023	0	0.0%
1847 Goedeker Inc.	February 14, 2022	6,103,824	5.0%
BioRestorative Therapies, Inc.	February 14, 2022	200,000	5.0%
BriaCell Therapeutics Corp.	February 14, 2022	900,000	4.7%
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.	February 14, 2022	363,000	5.0%

View Altium Capital Management LP's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G	2024-02-21
SC 13G	2024-02-20
13F-HR	2024-02-14
SC 13G/A	2024-02-13
SC 13G/A	2024-02-13
SC 13G/A	2024-02-13
SC 13G/A	2024-02-13
SC 13G/A	2024-02-13
SC 13G/A	2024-02-13
SC 13G/A	2024-02-13

View Altium Capital Management LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Altium Capital Management LP's holdings